|
|
|
||||||||||
Senior Lecturer, School of Pharmacy, University of Washington; Clinical Specialist and Diabetes Educator, Evergreen Community Health Care, Seattle, WA
Clinical Pharmacist, Harborview Medical Center; Clinical Instructor, Departments of Pharmacy and Family Medicine, University of Washington
Director of Research, University of Washington Physicians Network; Clinical Associate Professor, School of Medicine, University of Washington
Assistant Professor of Pharmacy Practice, College of Pharmacy & Health Sciences, Butler University; Clinical Pharmacist, Clarian Health Systems and Indiana University Methodist Family Practice Residency
Associate Professor, School of Pharmacy, University of Washington; Director, Geriatrics Program, School of Pharmacy, University of Washington
Reprints: Dr. Odegard, School of Pharmacy, University of Washington, Box 357630, 1959 NE Pacific St., Seattle, WA 98195-7630, fax 206/543-3835, podegard{at}u.washington.edu
BACKGROUND: There is limited information from randomized controlled studies about the influence of pharmacist interventions on diabetes control.
OBJECTIVE: To evaluate the effect of a pharmacist intervention on improving diabetes control; secondary endpoints were medication appropriateness and self-reported adherence.
METHODS: A randomized, controlled, multi-clinic trial was conducted
in the University of Washington Medicine Neighborhood Clinics. Seventy-seven
subjects,
18 years old with a hemoglobin (Hb) A1c
9% at
baseline and taking at least one oral diabetes medication, were randomized to
receive a pharmacist intervention (n = 43) or usual care (n = 34) for 6 months
followed by a 6-month usual-care observation period for both groups. Subjects
met with a clinical pharmacist to establish and initiate a diabetes care plan
followed by weekly visits or telephone calls to facilitate diabetes management
and adherence. HbA1c, medication appropriateness, and self-reported
adherence were assessed at baseline, 6 months, and 12 months.
RESULTS: The mean HbA1c did not differ between groups over the 12-month period (p = 0.61). A reduction in HbA1c was noted for both groups over time compared with baseline (p = 0.001); however, control subjects relied more heavily on provider visits. Medication appropriateness was not improved for diabetes medications (p = 0.65). Self-reported adherence was not significantly improved by the intervention.
CONCLUSIONS: This pharmacist intervention did not significantly improve diabetes control, but did allow for similar HbA1c control with fewer physician visits. Medication appropriateness and self-reported adherence compared with usual care in individuals with poorly controlled diabetes were not changed.
Key Words: diabetes, medication appropriateness, pharmacist intervention
Published Online, February 8, 2005. www.theannals.com, DOI 10.1345/aph.1E438
This article has been cited by other articles:
![]() |
B. Maack, D. R Miller, T. Johnson, and M. Dewey Economic Impact of a Pharmacy Resident in an Assisted Living Facility-Based Medication Therapy Management Program Ann. Pharmacother., November 1, 2008; 42(11): 1613 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Odegard and S. L. Gray Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus The Diabetes Educator, July 1, 2008; 34(4): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kreimer Washington State Forges Physician-Pharmacist Partnering DOC News, January 1, 2008; 5(1): 12 - 12. [Full Text] |
||||
![]() |
M. Machado, J. Bajcar, G. C Guzzo, and T. R Einarson Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management Ann. Pharmacother., October 1, 2007; 41(10): 1569 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Davis, R. M Clifford, W. A Davis, and K. T Batty The role of pharmaceutical care in diabetes management The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 352 - 356. [Abstract] [PDF] |
||||